Centre for Cardiovascular Biology and Disease Research, Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, Australia; Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea
Translational Biomedical Proteomics Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore
Elisa A Liehn
National Heart Research Institute, National Heart Centre Singapore, Singapore, Singapore; Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark; National Institute of Pathology "Victor Babes", Bucharest, Romania
Sharmelee Selvaraji
Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore, Singapore
Luting Poh
Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore
Vismitha Rajeev
Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore
Yoonsuk Cho
School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea
Yongeun Cho
School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea
Jongho Kim
School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea
Joonki Kim
Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore; Natural Products Research Center, Korea Institute of Science and Technology, Gangneung, Republic of Korea
Hannah LF Swa
Translational Biomedical Proteomics Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore
David Tan Zhi Hao
Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore
Chutima Rattanasopa
Translational Laboratories in Genetic Medicine, Agency for Science, Technology and Research, Singapore, Singapore; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore, Singapore
David Yang-Wei Fann
Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore
David Castano Mayan
Translational Laboratories in Genetic Medicine, Agency for Science, Technology and Research, Singapore, Singapore
Gavin Yong-Quan Ng
Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore
Sang-Ha Baik
Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore
Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore
Mathias Gelderblom
Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Grant R Drummond
Centre for Cardiovascular Biology and Disease Research, Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, Australia
Centre for Cardiovascular Biology and Disease Research, Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, Australia
Brian K Kennedy
Department of Physiology, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore; Department of Biochemistry, Yong Loo Lin School Medicine, National University of Singapore, Singapore, Singapore
Translational Biomedical Proteomics Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore; Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Intermittent fasting (IF) has been shown to reduce cardiovascular risk factors in both animals and humans, and can protect the heart against ischemic injury in models of myocardial infarction. However, the underlying molecular mechanisms behind these effects remain unclear. To shed light on the molecular and cellular adaptations of the heart to IF, we conducted comprehensive system-wide analyses of the proteome, phosphoproteome, and transcriptome, followed by functional analysis. Using advanced mass spectrometry, we profiled the proteome and phosphoproteome of heart tissues obtained from mice that were maintained on daily 12- or 16 hr fasting, every-other-day fasting, or ad libitum control feeding regimens for 6 months. We also performed RNA sequencing to evaluate whether the observed molecular responses to IF occur at the transcriptional or post-transcriptional levels. Our analyses revealed that IF significantly affected pathways that regulate cyclic GMP signaling, lipid and amino acid metabolism, cell adhesion, cell death, and inflammation. Furthermore, we found that the impact of IF on different metabolic processes varied depending on the length of the fasting regimen. Short IF regimens showed a higher correlation of pathway alteration, while longer IF regimens had an inverse correlation of metabolic processes such as fatty acid oxidation and immune processes. Additionally, functional echocardiographic analyses demonstrated that IF enhances stress-induced cardiac performance. Our systematic multi-omics study provides a molecular framework for understanding how IF impacts the heart’s function and its vulnerability to injury and disease.